Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
Tiny plastics in carotid plaque tied to elevated risk for heart attack, stroke, death
Among patients with asymptomatic carotid artery disease who had carotid endarterectomy, those whose atheromas contained microplastics and/or nanoplastics had worse outcomes than those whose atheromas did not, researchers reported.
Better sleep linked to improved verbal memory in multiple sclerosis
WEST PALM BEACH, Fla. — In two separate cohorts of individuals with multiple sclerosis and memory issues, better sleep was linked to improved verbal memory, according to a poster at ACTRIMS 2024.
Log in or Sign up for Free to view tailored content for your specialty!
Treatment with antibody oligonucleotide conjugate led to improved outcomes in DM1
Long-term treatment with IV administration of a novel therapeutic for those with myotonic dystrophy type 1 led to significant improvement in muscle strength and control and improved quality of life, data show.
Viltolarsen linked to increased pulmonary function in Duchenne muscular dystrophy
Treatment with viltolarsen at 48 weeks improved pulmonary function in a cohort of pediatric patients with Duchenne muscular dystrophy amenable to exon 53 skipping compared with those receiving standard care.
FDA grants breakthrough device designation to blood-based Alzheimer’s diagnostic assay
The FDA has granted breakthrough device designation to a phospho-tau 217 blood-based biomarker to assist in the diagnosis of Alzheimer’s disease, according to the manufacturer.
Givinostat improves range of motion, reduces decline of muscle function in DMD
Treatment with givinostat for ambulatory boys with Duchenne muscular dystrophy led to improved motion and reduced decline of muscle function and strength at 18 months, according to a poster at the 2024 MDA Clinical & Scientific Conference.
Zolgensma improves motor function at 52 weeks in spinal muscular atrophy
Treatment with Zolgensma improved motor function in a cohort of children with spinal muscular atrophy, according to a poster at the 2024 MDA Clinical & Scientific Conference.
Pamrevlumab nonsuperior to placebo for boys with Duchenne muscular dystrophy
For young ambulatory boys with Duchenne muscular dystrophy, treatment with pamrevlumab was nonsuperior to placebo after 52 weeks, according to a poster presentation at the 2024 MDA Clinical & Scientific Conference.
Addressing barriers to technology, telehealth care in underserved populations urgent
WEST PALM BEACH, Fla. — For patients with multiple sclerosis living in underserved areas, increasing access to health care professionals and removing barriers of access to technology are urgent needs, according to a speaker at ACTRIMS 2024.
FDA approves Acthar Gel SelfJect injector in autoimmune, inflammatory conditions
The FDA has approved a supplemental new drug application for an Acthar Gel injector for the treatment of several chronic and acute inflammatory and autoimmune conditions, according to the manufacturer.
-
Headline News
Cannabis, hallucinogen use ‘historically high’ among adults in 2023
September 16, 20243 min read -
Headline News
Long-term exposure to air pollution may increase infertility risk in men
September 13, 20243 min read -
Headline News
Catching up on sleep over the weekend may have heart health benefits
September 16, 20242 min read
-
Headline News
Cannabis, hallucinogen use ‘historically high’ among adults in 2023
September 16, 20243 min read -
Headline News
Long-term exposure to air pollution may increase infertility risk in men
September 13, 20243 min read -
Headline News
Catching up on sleep over the weekend may have heart health benefits
September 16, 20242 min read